BIMI International Medical Inc. Announces Corporate Name Change
BIMI International Medical Inc. (NASDAQ: BIMI) has officially changed its name from BOQI International Medical Inc. following shareholder approval on June 15, 2021. The amendment was filed with Delaware's Secretary of State and became effective on June 21, 2021. The company continues to trade under the same stock symbol, BIMI. Founded in 2006, BIMI specializes in healthcare products and operates two private hospitals in China. For further details, visit www.usbimi.com.
- None.
- Risks related to achieving profitable operations and continuing as a going concern.
- Uncertainties regarding meeting NASDAQ continued listing requirements.
- Potential impacts from COVID-19 on product and service demand in China.
NEW YORK, June 28, 2021 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a leading healthcare products and services provider in China, today announced that on June 15, 2021, the shareholders of the Company approved an amendment to the Company’s certificate of incorporation to change the Company’s name from BOQI International Medical Inc. to BIMI International Medical Inc. The Company’s common stock traded under the new name and the same symbol “BIMI”.
Accordingly, the Company filed a Certificate of Amendment to the Company’s certificate of incorporation with the Secretary of State of the State of Delaware, which became effective on June 21, 2021. The bylaws of the Company have also been updated with the new name.
About BIMI International Medical Inc.
BIMI International Medical Inc. was founded in 2006. The Company is now exclusively a healthcare products and provider, offering a broad range of healthcare products and related services and operates two private hospitals in China. For more information, please visit www.usbimi.com.
Safe Harbor Statement
Certain matters discussed in this news release are forward-looking statements that involve a number of risks and uncertainties including, but not limited to, the Company’s ability to achieve profitable operations, its ability to continue to operate as a going concern, its ability to continue to meet NASDAQ continued listing requirements, the effects of the spread of COVID-19, the demand for the Company’s products and services in the People’s Republic of China, general economic conditions and other risk factors detailed in the Company’s annual report and other filings with the United States Securities and Exchange Commission.
Investor Relations Contact:
Janice Wang
EverGreen Consulting Inc.
Email: IR@changqingconsulting.com
Phone: +1 571-464-9470 (from U.S.)
+86 13811768559 (from China)
FAQ
What is the new name of BIMI International Medical Inc. as of June 2021?
When did the name change for BIMI International Medical Inc. become effective?
What is the stock symbol for BIMI International Medical Inc.?
What type of services does BIMI International Medical Inc. provide?
What are some risks mentioned in BIMI's press release?
